mRNA-1345 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-07-30 in 1mo
ESTIMATED |
READOUT
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Target
Phase 3 · Respiratory Syncytial Virus |
ModernaTX, Inc. | mRNA-1345 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|